These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 31571405)

  • 1. Allosteric mechanism of an oximino-piperidino-piperidine antagonist for the CCR5 chemokine receptor.
    Zhang Y; Chen HF
    Chem Biol Drug Des; 2020 Jan; 95(1):113-123. PubMed ID: 31571405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-Based Design of 1-Heteroaryl-1,3-propanediamine Derivatives as a Novel Series of CC-Chemokine Receptor 5 Antagonists.
    Peng P; Chen H; Zhu Y; Wang Z; Li J; Luo RH; Wang J; Chen L; Yang LM; Jiang H; Xie X; Wu B; Zheng YT; Liu H
    J Med Chem; 2018 Nov; 61(21):9621-9636. PubMed ID: 30234300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of CC Chemokine Receptor 5 with a Potent Chemokine Antagonist Reveals Mechanisms of Chemokine Recognition and Molecular Mimicry by HIV.
    Zheng Y; Han GW; Abagyan R; Wu B; Stevens RC; Cherezov V; Kufareva I; Handel TM
    Immunity; 2017 Jun; 46(6):1005-1017.e5. PubMed ID: 28636951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity and structural analysis of GRL-117C: a novel small molecule CCR5 inhibitor active against R5-tropic HIV-1s.
    Nakata H; Maeda K; Das D; Chang SB; Matsuda K; Rao KV; Harada S; Yoshimura K; Ghosh AK; Mitsuya H
    Sci Rep; 2019 Mar; 9(1):4828. PubMed ID: 30886166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric and orthosteric sites in CC chemokine receptor (CCR5), a chimeric receptor approach.
    Thiele S; Steen A; Jensen PC; Mokrosinski J; Frimurer TM; Rosenkilde MM
    J Biol Chem; 2011 Oct; 286(43):37543-54. PubMed ID: 21878623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular interactions of CCR5 with major classes of small-molecule anti-HIV CCR5 antagonists.
    Kondru R; Zhang J; Ji C; Mirzadegan T; Rotstein D; Sankuratri S; Dioszegi M
    Mol Pharmacol; 2008 Mar; 73(3):789-800. PubMed ID: 18096812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CCR5 receptor-based mechanism of action of 873140, a potent allosteric noncompetitive HIV entry inhibitor.
    Watson C; Jenkinson S; Kazmierski W; Kenakin T
    Mol Pharmacol; 2005 Apr; 67(4):1268-82. PubMed ID: 15644495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An intracellular allosteric site for a specific class of antagonists of the CC chemokine G protein-coupled receptors CCR4 and CCR5.
    Andrews G; Jones C; Wreggett KA
    Mol Pharmacol; 2008 Mar; 73(3):855-67. PubMed ID: 18042736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Gymnastics: Mechanisms of HIV-1 Resistance to CCR5 Antagonists and Impact on Virus Phenotypes.
    Roche M; Borm K; Flynn JK; Lewin SR; Churchill MJ; Gorry PR
    Curr Top Med Chem; 2016; 16(10):1091-106. PubMed ID: 26324043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Filling the Gaps in Antagonist CCR5 Binding, a Retrospective and Perspective Analysis.
    Amerzhanova Y; Vangelista L
    Front Immunol; 2022; 13():826418. PubMed ID: 35126399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of potential CCR5 inhibitors through pharmacophore-based virtual screening, molecular dynamics simulation and binding free energy analysis.
    Wang J; Shu M; Wang Y; Hu Y; Wang Y; Luo Y; Lin Z
    Mol Biosyst; 2016 Oct; 12(11):3396-3406. PubMed ID: 27714030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure prediction of GPCRs using piecewise homologs and application to the human CCR5 chemokine receptor: validation through agonist and antagonist docking.
    Arumugam K; Crouzy S; Chevigne A; Seguin-Devaux C; Schmit JC
    J Biomol Struct Dyn; 2014; 32(8):1274-89. PubMed ID: 23869548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penicillixanthone A, a marine-derived dual-coreceptor antagonist as anti-HIV-1 agent.
    Tan S; Yang B; Liu J; Xun T; Liu Y; Zhou X
    Nat Prod Res; 2019 May; 33(10):1467-1471. PubMed ID: 29258357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting chemokine receptors for HIV: past, present and future.
    Fricker SP
    Future Med Chem; 2015; 7(17):2311-5. PubMed ID: 26627446
    [No Abstract]   [Full Text] [Related]  

  • 15. HIV co-receptor CCR5: structure and interactions with inhibitors.
    Wang T; Duan Y
    Infect Disord Drug Targets; 2009 Jun; 9(3):279-88. PubMed ID: 19519482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, SAR, and biological evaluation of oximino-piperidino-piperidine amides. 1. Orally bioavailable CCR5 receptor antagonists with potent anti-HIV activity.
    Palani A; Shapiro S; Josien H; Bara T; Clader JW; Greenlee WJ; Cox K; Strizki JM; Baroudy BM
    J Med Chem; 2002 Jul; 45(14):3143-60. PubMed ID: 12086500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational modeling of human coreceptor CCR5 antagonist as a HIV-1 entry inhibitor: using an integrated homology modeling, docking, and membrane molecular dynamics simulation analysis approach.
    Gadhe CG; Kothandan G; Cho SJ
    J Biomol Struct Dyn; 2013; 31(11):1251-76. PubMed ID: 23153179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular binding mode of PF-232798, a clinical anti-HIV candidate, at chemokine receptor CCR5.
    Zhu Y; Zhao YL; Li J; Liu H; Zhao Q; Wu BL; Yang ZL
    Acta Pharmacol Sin; 2019 Apr; 40(4):563-568. PubMed ID: 29941870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and biological evaluation of novel piperidine-4-carboxamide derivatives as potent CCR5 inhibitors.
    Hu S; Gu Q; Wang Z; Weng Z; Cai Y; Dong X; Hu Y; Liu T; Xie X
    Eur J Med Chem; 2014 Jan; 71():259-66. PubMed ID: 24316669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances of CCR5 antagonists: From small molecules to macromolecules.
    Qi B; Fang Q; Liu S; Hou W; Li J; Huang Y; Shi J
    Eur J Med Chem; 2020 Dec; 208():112819. PubMed ID: 32947226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.